| Tiazac Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Tiazac 120 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
| Tiazac 360 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
| Tiazac 240 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
| Tiazac 300 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
| Tiazac 420 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
| Tiazac 180 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
Posted by ebiker over 4 years ago
65 year old male was on Tiazac 120mg for a while to control BP. Didn't seem to help, so Rx upped dosage to 240mg. Experienced...
Posted by jbw53 over 4 years ago
trouble falling asleep and staying asleep, anxiety,
Posted by frank.pasciuto over 5 years ago
Muscle pain, bicepts,tricepts, pls let me know if any one else is experiencing this?
Biovail Announces Canadian Commercial Availability of 1000mg ... - PR-Inside.com (Pressemitteilung)
BPC markets and distributes a select portfolio of products, including Wellbutrin XL(R), Tiazac(R) XC, Ralivia(TM), Glumetza(TM), Zyban(R) and Monocor(R).
Thu Jan 24 08:54:56 -0500 2008
KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 ... - Trading Markets (press release)
... in pain management and cardiovascular product lines -- Continued growth of Diltiazem hcl Extended Release Capsules (Tiazac(R) - Forest Pharmaceuticals, ...
Tue Nov 20 07:50:05 -0500 2007
Biovail's Steinbach Manufacturing Facility Receives Prestigious ... - Canada NewsWire (press release)
... LA and Tiazac(R) XC; as such, it plays a critically important role in Company operations," says Biovail Chief Executive Officer Dr. Douglas Squires. ...
Thu Nov 01 14:20:58 -0400 2007
diltiazem hydrochloride - A benzothiazepine calcium channel blocking agent. Diltiazem hydrochloride inhibits the transmembrane influx of extracellular calcium ions into select myocardial and vascular smooth muscle cells, causing dilatation of coronary and systemic arteries and decreasing myocardial contractility. Because of its vasodilatory activity, this agent has been shown to improve the microcirculation in some tumors, thereby potentially improving the delivery of antineoplastic agents to tumor cells. (NCI04)